Derek M. Meisner, Chief Legal Officer & Corporate Secretary at Acumen Pharmaceuticals, Inc. (ABOS), sold 3,418 shares at $1.59 ($5K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($5k) by Chief Legal Officer & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABOS | SELL | 2026-01-28 | $107K | — | Filing → |
| ABOS | SELL | 2026-01-23 | $31K | — | Filing → |
| ABOS | SELL | 2026-01-12 | $182K | — | Filing → |